Literature DB >> 3904135

New aspects of pathogenesis of lower urinary tract infections.

J D Sobel.   

Abstract

Current theories about the pathogenesis and immunology of urinary tract infections (UTI) and the role of host defense mechanisms are discussed. The ascending route of infection is responsible for the vast majority of UTI, and colonization of the periurethral region by group-specific Escherichia coli precedes the development of UTI. Several bacterial virulence factors have been identified in organisms responsible for UTI. In urine, the most important inhibitory factors are a very high or low osmolality, a high urea concentration, a high organic acid concentration, and a low pH. There are many new antimicrobial agents which facilitate the process of bacterial eradication, especially of microorganisms that were resistant to previously available antibiotics.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3904135

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  In Vitro and In Vivo Activities of DS86760016, a Novel Leucyl-tRNA Synthetase Inhibitor for Gram-Negative Pathogens.

Authors:  Kedar P Purnapatre; Madhvi Rao; Manisha Pandya; Alka Khanna; Tridib Chaira; Ramesh Bambal; Dilip J Upadhyay; Nobuhisa Masuda
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

2.  Secondarily infected nonstruvite urolithiasis: a prospective evaluation.

Authors:  Mitra R de Cógáin; John C Lieske; Terri J Vrtiska; Pritish K Tosh; Amy E Krambeck
Journal:  Urology       Date:  2014-10-11       Impact factor: 2.649

Review 3.  The Basics of Bacteriuria: Strategies of Microbes for Persistence in Urine.

Authors:  Deepak S Ipe; Ella Horton; Glen C Ulett
Journal:  Front Cell Infect Microbiol       Date:  2016-02-08       Impact factor: 5.293

Review 4.  L-form bacteria, chronic diseases and the origins of life.

Authors:  Jeff Errington; Katarzyna Mickiewicz; Yoshikazu Kawai; Ling Juan Wu
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-11-05       Impact factor: 6.237

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.